Skip to main content

Table 4 Pharmacokinetic parameters obtained from Plasma concentration vs time data for an oral dose of Montek 10 and MTS ChrDDS

From: IVIVC assessment, pharmacokinetic evaluation, and X-ray radiography mapping of Novel Parteck® SRP 80 and hypromellose-loaded LTD4 receptor antagonist chronosystem

S. no.

Parameters (n = 4)

ChrDDS (equivalent to 10 mg)

Marketed (equivalent to 10 mg)

1

Cmax (ng/ml)

490.16 ± 33.95*

648.29 ± 121.63*

2

Tmax (h)

9 ± 0.5*

2 ± 0.9*

3

AUC0–24 (ng h/ml)

4958.51 ± 418.29*

2181.65 ± 309.18*

4

AUC0-∞ (ng h/ml)

6094.84 ± 531.11*

3486.36 ± 413.61*

5

T1/2 (h)

7.27 ± 0.71*

2.37 ± 1.04*

6

Mean residence time (MRT) (h)

14.08 ± 1.21*

2.39 ± 1.11*

7

Vd (ml)

1.204 ± 0.18*

0.684 ± 0.11*

8

CL (ml/h)

0.112 ± 0.05*

0.200 ± 0.08*

9

Tlast (h)

24*

4.5*

  1. *p value < 0.005 significantly different